Key facts
- This page summarizes John E. Davis's Form 4 filing for ARTIVION, INC. (AORT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Mar 2025, 17:06.
John E. Davis - 06 Mar 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- AORT
- Reported as of
- 06 Mar 2025
- Net transaction value
- -$64,939
- SEC form
- 4
- Accepted by SEC
- 10 Mar 2025, 17:06:01 UTC
- Prior SEC filing
- 04 Mar 2025
- Next SEC filing
- 12 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ John E. Davis
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Davis filed Form 4 for ARTIVION, INC. (AORT) on 10 Mar 2025.
Change
- Previous filing in this sequence was filed on 04 Mar 2025.
- Current net transaction value: -$64,939.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AORT
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +25,654
- Change %
- +14%
- Price
- $0.000000
- Shares after
- 210,586
- Date
- 06 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
AORT
transaction
Common Stock
Sale
- Transaction value
- $64,939
- Shares
- -2,618
- Change %
- -1.2%
- Price
- $24.80
- Shares after
- 207,968
- Date
- 06 Mar 2025
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents performance stock units granted on February 23, 2024. One third (1/3) were issued on March 6, 2025. The remaining shares earned in connection with the February 2024 grant will be eligible to vest and be issued as follows: one third (1/3) on February 23, 2026; and one third (1/3) on February 23, 2027, assuming employment on the relevant vesting date.
Footnote F2
These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.